-
Je něco špatně v tomto záznamu ?
The role of protease-activated receptor type 2 in nociceptive signaling and pain
P. Mrozkova, J. Palecek, D. Spicarova
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články, přehledy
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- kationtové kanály TRP metabolismus MeSH
- lidé MeSH
- mícha metabolismus MeSH
- nádorová bolest metabolismus MeSH
- neuralgie metabolismus MeSH
- nocicepce * MeSH
- nociceptivní bolest metabolismus MeSH
- proteinkinasy metabolismus MeSH
- receptor PAR-2 metabolismus MeSH
- signální transdukce MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Protease-activated receptors (PARs) belong to the G-protein-coupled receptor family, that are expressed in many body tissues especially in different epithelial cells, mast cells and also in neurons and astrocytes. PARs play different physiological roles according to the location of their expression. Increased evidence supports the importance of PARs activation during nociceptive signaling and in the development of chronic pain states. This short review focuses on the role of PAR2 receptors in nociceptive transmission with the emphasis on the modulation at the spinal cord level. PAR2 are cleaved and subsequently activated by endogenous proteases such as tryptase and trypsin. In vivo, peripheral and intrathecal administration of PAR2 agonists induces thermal and mechanical hypersensitivity that is thought to be mediated by PAR2-induced release of pronociceptive neuropeptides and modulation of different receptors. PAR2 activation leads also to sensitization of transient receptor potential channels (TRP) that are crucial for nociceptive signaling and modulation. PAR2 receptors may play an important modulatory role in the development and maintenance of different pathological pain states and could represent a potential target for new analgesic treatments.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17012744
- 003
- CZ-PrNML
- 005
- 20170424110714.0
- 007
- ta
- 008
- 170412s2016 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.933269 $2 doi
- 035 __
- $a (PubMed)27070742
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Mrozkova, P. $u Department of Functional Morphology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
- 245 14
- $a The role of protease-activated receptor type 2 in nociceptive signaling and pain / $c P. Mrozkova, J. Palecek, D. Spicarova
- 520 9_
- $a Protease-activated receptors (PARs) belong to the G-protein-coupled receptor family, that are expressed in many body tissues especially in different epithelial cells, mast cells and also in neurons and astrocytes. PARs play different physiological roles according to the location of their expression. Increased evidence supports the importance of PARs activation during nociceptive signaling and in the development of chronic pain states. This short review focuses on the role of PAR2 receptors in nociceptive transmission with the emphasis on the modulation at the spinal cord level. PAR2 are cleaved and subsequently activated by endogenous proteases such as tryptase and trypsin. In vivo, peripheral and intrathecal administration of PAR2 agonists induces thermal and mechanical hypersensitivity that is thought to be mediated by PAR2-induced release of pronociceptive neuropeptides and modulation of different receptors. PAR2 activation leads also to sensitization of transient receptor potential channels (TRP) that are crucial for nociceptive signaling and modulation. PAR2 receptors may play an important modulatory role in the development and maintenance of different pathological pain states and could represent a potential target for new analgesic treatments.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a nádorová bolest $x metabolismus $7 D000072716
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a neuralgie $x metabolismus $7 D009437
- 650 12
- $a nocicepce $7 D059225
- 650 _2
- $a nociceptivní bolest $x metabolismus $7 D059226
- 650 _2
- $a proteinkinasy $x metabolismus $7 D011494
- 650 _2
- $a receptor PAR-2 $x metabolismus $7 D044464
- 650 _2
- $a signální transdukce $7 D015398
- 650 _2
- $a mícha $x metabolismus $7 D013116
- 650 _2
- $a kationtové kanály TRP $x metabolismus $7 D050051
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Paleček, Jan $7 xx0089354 $u Department of Functional Morphology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Špicarová, Diana $7 xx0245944 $u Department of Functional Morphology, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 65, č. 3 (2016), s. 357-367
- 856 41
- $u http://www.biomed.cas.cz/physiolres/ $y domovská stránka časopisu
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 4 $z 0
- 990 __
- $a 20170412 $b ABA008
- 991 __
- $a 20170420131100 $b ABA008
- 999 __
- $a ok $b bmc $g 1201679 $s 973517
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 65 $c 3 $d 357-367 $e 20160412 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK118 $a Pubmed-20170412